Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jul 12, 2020 11:36am
67 Views
Post# 31257372

RE:RE:RE:RE:this traded 1,5 million shares on nasdaq last week

RE:RE:RE:RE:this traded 1,5 million shares on nasdaq last weekIt has been years they have been talking about partnerships.  At one point P Laurin said they had 20 companies talking with them.  End result was we hired that consulting firm two years ago and they got us nothing.

Dilution is coming as they are running out of money.

Good question on BLA delay.  The FDA process changes supposedly completed Sept 2019.  Paper work should have been done months ago IMO.  LMNL has moved the date twice already, would not be 


StockReddy wrote:
Next NEWS will be partnership with big pharma, and it is possible. In worst case scenario, they will go for dilution and that we do not want to see.
What is the reason behind not submitting the BLA? 

IMHO


<< Previous
Bullboard Posts
Next >>